Landmark Ideas Series: Dr. Ran Balicer

Speaker: Ran Bailcer, MD, PhD, at Clalit Health Services

Date: March 2, 2023 at 4:00PM - 5:30PM

Talk details will be forthcoming.

Ran D. Balicer, a public health physician and researcher, serves as Chief Innovation Officer and Founding Director of the Clalit Research Institute at Clalit - Israel's largest healthcare organization. In these roles, he is responsible for strategic planning and development of innovative organization-wide interventions for improving healthcare quality, reducing disparities, and introducing novel data and AI driven tools into practice to increase care effectiveness. 

Prof. Balicer has been affiliated as faculty with the Ben-Gurion University since 2004, involved in research and teaching in the School of Public Health, and serves today as full professor and track director in the faculty' MPH program. He authored books, book chapters and over 250 peer-reviewed publications looking at various aspects of real world evidence generation, public health, quality improvement, and preventive medicine. In recent years, Prof. Balicer's research is focused on the study of extensive clinical databases in care provision and policymaking, as well as in applying and assessing innovative models of care aimed at increasing the effectiveness of non-communicable diseases care. In parallel, he is involved in the study of emerging infectious diseases prevention and control, through modeling and real-life big data.

Prof. Balicer serves as Chair of the Israeli Society for Quality in Healthcare, as an Advisor to Israeli Ministry of Health on infectious disease epidemiology, health policy and emergency preparedness. He also served as a Board Member of the International Foundation for Integrated Care and of the European Federation of Medical Informatics.

Prof. Balicer serves in senior advisory groups to the World Health Organization (WHO) Regional Office for Europe - including the Region’s Senators Group, and is involved in projects focusing on chronic diseases monitoring, prevention and control, and healthcare systems integration. 

Since 2020, Prof. Balicer serves as Chair of Israel’s National Expert Advisory Team to the government on Covid-19 response. 


Publications

Hopper RK, Abman SH, Elia EG, Avitabile CM, Yung D, Mullen MP, Austin ED, Bates A, Handler SS, Feinstein JA, Ivy DD, Kinsella JP, Mandl KD, Raj JU, Sleeper LA, . Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry. The Journal of pediatrics 2022.

Wang X, Zhang HG, Xiong X, Hong C, Weber GM, Brat GA, Bonzel CL, Luo Y, Duan R, Palmer NP, Hutch MR, Gutiérrez-Sacristán A, Bellazzi R, Chiovato L, Cho K, Dagliati A, Estiri H, García-Barrio N, Griffier R, Hanauer DA, Ho YL, Holmes JH, Keller MS, Klann MEng JG, L'Yi S, Lozano-Zahonero S, Maidlow SE, Makoudjou A, Malovini A, Moal B, Moore JH, Morris M, Mowery DL, Murphy SN, Neuraz A, Yuan Ngiam K, Omenn GS, Patel LP, Pedrera-Jiménez M, Prunotto A, Jebathilagam Samayamuthu M, Sanz Vidorreta FJ, Schriver ER, Schubert P, Serrano-Balazote P, South AM, Tan ALM, Tan BWL, Tibollo V, Tippmann P, Visweswaran S, Xia Z, Yuan W, Zöller D, Kohane IS, Avillach P, Guo Z, Cai T, . SurvMaximin: Robust federated approach to transporting survival risk prediction models. Journal of biomedical informatics 2022.

Torous J, Stern AD, Bourgeois FT. Regulatory considerations to keep pace with innovation in digital health products. NPJ digital medicine 2022.

Levy S, Wisk LE, Minegishi M, Ertman B, Lunstead J, Brogna M, Weitzman ER. Association of Screening and Brief Intervention With Substance Use in Massachusetts Middle and High Schools. JAMA network open 2022.

Nielsen M, Presti M, Sztupinszki Z, Jensen AWP, Draghi A, Chamberlain CA, Schina A, Yde CW, Wojcik J, Szallasi Z, Crowther MD, Svane IM, Donia M. Co-existing alterations of MHC class I antigen presentation and IFNγ signaling mediate acquired resistance of melanoma to post-PD-1 immunotherapy. Cancer immunology research 2022.